PRMT1-mediated modification of H4R3me2a promotes liver cancer progression by enhancing the transcriptional activity of SOX18

This study revealed the clinical relevance of histone H4R3me2a modification in HCC and demonstrated that PRMT1 promotes malignant behavior in HCC cells by modulating H4R3me2a modification in the SOX18 promoter region. The findings elucidate the role and molecular mechanism of PRMT1-mediated histone H4R3me2a modification in HCC progression and highlight the potential clinical applications of PRMT1 inhibitors. These results may provide new insights into the treatment of HCC.

Authors

Institutions

Publication Details

Journal
Hepatology Communications
Published
2025-03-24
DOI
https://doi.org/10.1097/hc9.0000000000000647
Citations
3
Primary Topic
Cancer-related gene regulation
Type
article
Field-Weighted Citation Impact
2.42
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PRMT1-mediated modification of H4R3me2a promotes liver cancer progression by enhancing the transcriptional activity of SOX18

Hongyi Zhu, Siying Wang, Haojie Jin, Chenhe Yi et al.
3 citations
Hepatology Communications
Cancer-related gene regulation
2.42
article

PRMT1-mediated modification of H4R3me2a promotes liver cancer progression by enhancing the transcriptional activity of SOX18

Hongyi Zhu, Siying Wang, Haojie Jin, Chenhe Yi, Qiangxin Wu, Wenxin Qin, Jinhong Chen, Xingling Zheng, Yuanyuan Lv, Yangyang Zhou, Jiaojiao Zheng, Shenghan Lou, Wei Wu, Qi Li, Haoyu Li, Xiaoxiao Sun, Ling Jing, Ruobing Yu
article en
3 citations

Abstract

This study revealed the clinical relevance of histone H4R3me2a modification in HCC and demonstrated that PRMT1 promotes malignant behavior in HCC cells by modulating H4R3me2a modification in the SOX18 promoter region. The findings elucidate the role and molecular mechanism of PRMT1-mediated histone H4R3me2a modification in HCC progression and highlight the potential clinical applications of PRMT1 inhibitors. These results may provide new insights into the treatment of HCC.

Hepatology CommunicationsVol. 9(4)
Shanghai Jiao Tong University (CN), Fudan University (CN), Renji Hospital (CN), Shanghai Cancer Institute (CN), Shanghai First People's Hospital (CN), Huashan Hospital (CN)
No poverty, Good health and well-being
Openalex Percentile: Top 12%
Cancer-related gene regulation
2.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

PRMT1-mediated modification of H4R3me2a promotes liver cancer progression by enhancing the transcriptional activity of SOX18 — Hongyi Zhu, Siying Wang, et al. · Hepatology Communications (2025) | TGRS Research Map | TGRS